Jump to content

Recommended Posts

So we lose another head office.


Medtronic buying CryoCath

9/25/2008 9:25:48 AM

Comments (0)


Post-Bulletin and news service reports


Medtronic Inc. is paying about $400 million to buy a Canadian medical device company that has worked with Mayo Clinic.


This morning, Minneapolis-based medical device maker Medtronic announced that it is buying Montreal-based CryoCath Technologies Inc.


CryoCath has accepted the offer of $8.75 per share, about $380 million total.


CyroCath makes a heart catheter used to treat atrial fibulation.


Mayo Clinic participated in a clinical study, along with Massachusetts General Hospital in Boston, of CryoCath's Arctic Front catheter.


Dr. Douglas Packer of Mayo Clinic presented the results of the study at the Annual International Boston Atrial Fibrillation Symposium in 2006.


In today's announcement, Medtronic explained why it is interested in CyroCath.


"Medtronic estimates that up to five million patients worldwide are impacted by atrial fibrillation," said Pat Mackin of Medtronic. "Medtronic and physicians are interested in procedures that are safer, faster and less complex so that more patients can benefit from treatment."

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...